View in EDS

271P Cost-effectiveness of pembrolizumab as monotherapy or in combination with chemotherapy versus EXTREME regimen for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in Taiwan.

Saved in:
Bibliographic Details
Title: 271P Cost-effectiveness of pembrolizumab as monotherapy or in combination with chemotherapy versus EXTREME regimen for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in Taiwan.
Authors: Wang, C.H.1, Lei, H.L.2, Borse, R.3, Chirovsky, D.3, Chien, L.2, Tan, S.C.4, Spiteri, C.5
Source: Annals of Oncology. 2020 Supplement 6, Vol. 31, pS1349-S1349. 1p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 152684778
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 271P Cost-effectiveness of pembrolizumab as monotherapy or in combination with chemotherapy versus EXTREME regimen for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in Taiwan.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wang%2C+C%2EH%2E%22">Wang, C.H.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Lei%2C+H%2EL%2E%22">Lei, H.L.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Borse%2C+R%2E%22">Borse, R.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Chirovsky%2C+D%2E%22">Chirovsky, D.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Chien%2C+L%2E%22">Chien, L.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Tan%2C+S%2EC%2E%22">Tan, S.C.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Spiteri%2C+C%2E%22">Spiteri, C.</searchLink><relatesTo>5</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2020 Supplement 6, Vol. 31, pS1349-S1349. 1p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152684778
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2020.10.265
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 1
        StartPage: S1349
    Titles:
      – TitleFull: 271P Cost-effectiveness of pembrolizumab as monotherapy or in combination with chemotherapy versus EXTREME regimen for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in Taiwan.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang, C.H.
      – PersonEntity:
          Name:
            NameFull: Lei, H.L.
      – PersonEntity:
          Name:
            NameFull: Borse, R.
      – PersonEntity:
          Name:
            NameFull: Chirovsky, D.
      – PersonEntity:
          Name:
            NameFull: Chien, L.
      – PersonEntity:
          Name:
            NameFull: Tan, S.C.
      – PersonEntity:
          Name:
            NameFull: Spiteri, C.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 11
              Text: 2020 Supplement 6
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 31
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1